Welcome to LookChem.com Sign In|Join Free
  • or
4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE is a chemical compound that belongs to the benzaldehyde class. It is characterized by its yellowish liquid appearance and possesses a molecular formula of C14H11ClO2 with a molecular weight of 248.69 g/mol. 4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE is known for its unique chemical properties, making it a versatile component in various industrial applications.

70627-21-3

Post Buying Request

70627-21-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70627-21-3 Usage

Uses

Used in Organic Synthesis:
4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE is used as a key intermediate in organic synthesis for the production of other chemicals. Its unique structure allows for the creation of a wide range of chemical compounds, contributing to the diversity of chemical products.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE is utilized as an intermediate in the synthesis of various drugs. Its chemical properties make it a valuable component in the development of new medications, potentially leading to advancements in healthcare.
Used in Agrochemical Industry:
4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE also finds application in the agrochemical industry, where it serves as an intermediate in the production of agrochemicals. Its role in this industry is crucial for the development of effective agricultural products that contribute to increased crop yields and protection against pests.
Used in Fragrance Industry:
In the fragrance industry, 4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE is employed for its aromatic properties. It is used in the preparation of various fragrances, adding to the complexity and richness of scents in perfumes, cosmetics, and other scented products.
Used in Medicinal Chemistry and Drug Development:
Due to its unique chemical properties, 4-[(2-CHLOROBENZYL)OXY]BENZALDEHYDE has potential applications in the field of medicinal chemistry and drug development. Researchers can leverage its characteristics to design and develop new pharmaceutical compounds, potentially leading to breakthroughs in the treatment of various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 70627-21-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,2 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 70627-21:
(7*7)+(6*0)+(5*6)+(4*2)+(3*7)+(2*2)+(1*1)=113
113 % 10 = 3
So 70627-21-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H11ClO2/c15-14-4-2-1-3-12(14)10-17-13-7-5-11(9-16)6-8-13/h1-9H,10H2

70627-21-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(2-chlorophenyl)methoxy]benzaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:70627-21-3 SDS

70627-21-3Relevant academic research and scientific papers

Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells

Zhao, Shuangmei,Zhen, Yongqi,Fu, Leilei,Gao, Feng,Zhou, Xianli,Huang, Shuai,Zhang, Lan

supporting information, (2019/08/20)

Sodium taurocholate cotransport polypeptide (NTCP) plays an important role in the development of hepatitis and acts as a switch to allow hepatitis virus to enter hepatic cells. As the entry receptor protein of hepatitis virus, NTCP is also an effective ta

Synthesis and analysis of anticonvulsant activities of new 4-[2-(4-alkoxybenzylamino)ethyl]-2H-1,2,4-triazol-3(4H)-one derivatives

Shen, Qing-Kun,Wang, Shi-Ben,Gong, Guo-Hua,Yin, Xiu-Mei,Quan, Zhe-Shan

, p. 430 - 438 (2015/06/22)

The present study involved the design and synthesis of new substituted 4-[2-(4-alkoxybenzylamino) ethyl]-2H-1,2,4-triazol-3(4H)-one derivatives (8a-w) starting from 1,2-ethanediamine. The final compounds were screened for their in vivo anticonvulsant activities and neurotoxicities by maximal electroshock (MES) and rotarod tests, respectively. Among the compounds studied, 4-[2-(4-butoxybenzylamino)ethyl]-2H-1,2,4-triazol-3(4H)-one hydrochloride (8b) was found by intraperitoneal administration in mice to be the most potent compound with a median effective dose (ED50) value of 33.2 mg/kg and a high protective index (PI) value of 11.4. Compound 8b showed significant oral activity against MES-induced seizures in mice with an ED50 value of 83.1 mg/kg and a PI of 18.1. The results demonstrated that compound 8b possessed better anticonvulsant activity and higher safety than the marketed drug carbamazepine.

Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone

Zheng, Chang-Ji,Song, Ming-Xia,Wu, Yan,Sun, Liang-Peng,Li, Yin-Jing,Piao, Hu-Ri,Jin, Xin,Yu, Li-Jun

, p. 203 - 209,7 (2012/12/12)

Four novel series of compounds, including the l-phenylalanine-derived C5-substituted rhodanine (6a-q, 7a-j) and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone (9a-e, 11a-e) have been designed, synthesized, characterized, and evaluated for their antibacterial activity. Some of these compounds showed significant antibacterial activity against Gram-positive bacterias, especially against the strains of multidrug-resistant clinical isolates, among which compounds 6c-e, 6g, 6i, 6j and 6q exhibiting high levels of antimicrobial activity against Staphylococcus aureus RN4220 with minimum inhibitory concentration (MIC) values of 2 μg/mL. Compound 6q showed the most potent activity of all of the compounds against all of the test multidrug-resistant clinical isolates tested. Unfortunately, however, none of the compounds were active against Gram-negative bacteria at 64 μg/mL.

Isoxazol-5(4H)one derivatives as PTP1B inhibitors showing an anti-obesity effect

Kafle, Bhooshan,Aher, Nilkanth G.,Khadka, Deegendra,Park, Hwangseo,Cho, Hyeongjin

supporting information; experimental part, p. 2073 - 2079 (2011/11/05)

In developing inhibitors of therapeutic target enzymes, significant time and effort are committed to the preparation of large numbers of compounds. In an effort to develop a potent inhibitor of protein tyrosine phosphatase (PTP) 1B as an anti-obesity and/or anti-diabetic agent, we constructed an isoxazolone chemical library by using a simplified procedure that circumvents tedious workup and purification steps. The 10× 7 isoxazolone derivatives were synthesized by coupling the two halves of the target compounds. When mixed and heated in test tubes, the precursors produced the reaction products as precipitates. After brief washing, the products were pure enough to be used for enzymatic experiments. With the precursors for the coupling reactions prepared, the 10× 7 library compounds could be prepared in a day by using the present protocol. The library compounds thus obtained were examined for their inhibitory activities against PTP1B. Among them, compound C3 was the most potent inhibitor of PTP1B with an IC50 of 2.3 μM. The in vivo effect of C3 was also examined in an obesity-prone mouse strain. Diet-induced obese (DIO)/diabetic mice were divided into two groups and each group was fed a high-fat diet (HFD) or HFD+C3 for four weeks. The group of C3-fed mice gained significantly less weight relative to the HFD-fed control group during the four weeks of the drug feeding period. In contrast to the anti-obesity effect of C3, no difference was observed in the glycemic control of the HFD and HFD+C3 mice groups.

Selective and potent monoamine oxidase type B inhibitors: substituted semicarbazones and acylhydrazones of aromatic aldehydes and ketones

Bernard, S.,Paillat, C.,Oddos, T.,Seman, M.,Milcent, R.

, p. 471 - 482 (2007/10/02)

The synthesis and the evaluation of the monoamine oxidase A and B inhibitory activities of 21 new substituted acylhydrazones of various aromatic aldehydes and 4-(benzyloxy)acetophenone, and four substituted semicarbazones of benzaldehyde and 4-(benzyloxy)benzaldehyde, are described.The 4-(benzyloxy)phenyl group contributing to a high lipophilicity led to the most active compounds.One of these, compound 3g (IC50 = 3 nM, MAO A/MAO B selectivity > 33 000), was found to act as a revervible and probably tight-binding inhibitor.The studied acyclic hydrazones and semicarbazones are structurally related to other reversible and potent inhibitors, eg, heterocyclic compounds such as 1,3,4-oxadiazol-2(3H)-one derivatives in which the hydrazono group is intracyclic.Some of these new inhibitors might find use in the symptomatic treatment of neurodegenerative processes.MAO B inhibitor / hydrazone (aromatic acyl-) / semicarbazone (aromatic)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 70627-21-3